Pancreatic cancer patients who underwent chemotherapy both before and after surgery had longer survival rates compared to those who received...
Vous n'êtes pas connecté
Administering chemotherapy before surgery has shown benefits for select pancreatic cancer patients potentially improving treatment outcomes and survival rates.
Pancreatic cancer patients who underwent chemotherapy both before and after surgery had longer survival rates compared to those who received...
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from...
A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
MONDAY, June 24, 2024 -- Giving people with pancreatic cancer chemotherapy both before and after a tumor-removing surgery brought better outcomes...
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be...
The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...
Patients had numerically better but statistically similar five-year overall survival rates for IMRT (30.8 per cent) compared to 3D-CRT (26.6 per...
An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...
Chemotherapy treatment in breast cancer patients disrupts the delicate balance of the gut microbiome, affecting microbial diversity and composition.